End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
4,210 KRW | -8.08% | +20.46% | -2.55% |
2023 | Kainos Medicine, Inc.(KOSDAQ:A284620) dropped from S&P Global BMI Index | CI |
2022 | Kainos Medicine, Inc. announced that it has received KRW 2.00000052 billion in funding from SC United Co., Ltd. | CI |
1st Jan change | Capi. | |
---|---|---|
-2.55% | 9.34Cr | |
+26.08% | 4.5TCr | |
-0.74% | 4.26TCr | |
+46.00% | 4.18TCr | |
-5.31% | 2.9TCr | |
+9.52% | 2.61TCr | |
-21.48% | 1.9TCr | |
+6.12% | 1.28TCr | |
+27.59% | 1.21TCr | |
-3.32% | 1.18TCr |
- Stock Market
- Equities
- A284620 Stock
- News Kainos Medicine, Inc.
- FAScinate Therapeutics, Inc. announced that it has received KRW 18.100000475 billion in funding from Kainos Medicine, Inc.